Source: Center Watch

TransCellScience: BioreclamationIVT acquires TransCell Science

BioreclamationIVT has acquired TransCell Science, a privately held CRO specializing in the use of primary cells for phenotypic screening assays. With its scientific expertise in the areas of cell culture and cell-based assays, clients have looked to TransCell as a partner in developing protocols and conducting studies that provide pertinent data for their research programs. [...]The post BioreclamationIVT acquires TransCell Science appeared first on CenterWatch News Online.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Chris Hansis's photo - Founder & CEO of TransCellScience

Founder & CEO

Chris Hansis

CEO Approval Rating

70/100

Read more